FASLG and autoimmune polyendocrinopathy: The levels of IgG aβ2GP1-D1 antibodies were also evaluated in APS patients with the triple aPL positivity, double aPL positivity, and single aPL positivity, as triple aPL positivity has been considered as a risk factor for aPL-mediated clinical manifestations6.